Rise Therapeutics

Developer of targeted immunological-based biologics for gastrointestinal (GI) inflammatory disease

placeRockville, Maryland, United States calendar_todayFounded 2016 groups10 employees language risetherapeutics.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 20 times.

YearFilings
20221
20241
20251

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon